心力衰竭患者什么时候应该关掉ICD ?

Q2 Medicine Heart Asia Pub Date : 2019-04-01 DOI:10.1136/heartasia-2019-apahff.10
L. Cheung
{"title":"心力衰竭患者什么时候应该关掉ICD ?","authors":"L. Cheung","doi":"10.1136/heartasia-2019-apahff.10","DOIUrl":null,"url":null,"abstract":"It is well documented that implantable cardioverter defibrillator (ICD) saves lives in populations at risk for sudden death. However, mortality in advanced heart failure remains high despite advances in therapy.1 Twenty per cent of ICD patients receiving shocks in the final weeks of their lives experience pain and decreased quality of life, causing distress to patients and their families.2 Ethically and legally, there are no differences between refusing ICD therapy and requesting withdrawal of ICD therapy. Carrying out a request to withdraw life-sustaining treatment is neither physician-assisted suicide nor euthanasia.3 Decisions about deactivation of ICD are complicated. Proactive communication by clinicians before implant and during device follow-up are important in order to minimise suffering as the end of life nears for patients with ICDs. Clear discussion about the benefits and burdens of the device should be made. Advance care planning addressing device deactivation should be encouraged for all patients with ICD.4 References Goldberger Z, Lampert R. Implantable Cardioverter-defibrillators: expanding indications and technologies. JAMA 2006;295;809–818 Goldstein NE, Lampert R, Bradley E, Lynn J, Krumholz HM. Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med2004;141:835–838. Lampert R, Hayes DL, Annas GJ, Farley MA, Goldstein NE, Hamilton RM, Kay GN, Kramer DB, Mueller PS, Padeletti L, Pozuelo L, Schoenfeld MH, Vardas PE, Wiegand DL, Zellner R; American College of Cardiology; American Geriatrics Society; American Academy of Hospice and Palliative Medicine; American Heart Association; European Heart Rhythm Association; Hospice and Palliative Nurses Association. HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm2010;7:1008–1026. BHF. ICD deactivation at the end of life: Principles and practice. 2013. https://www.bhf.org.uk/-/media/files/publications/hcps/icd-deactivation.pdf","PeriodicalId":12858,"journal":{"name":"Heart Asia","volume":"11 1","pages":"A5 - A5"},"PeriodicalIF":0.0000,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/heartasia-2019-apahff.10","citationCount":"0","resultStr":"{\"title\":\"10 When is it time to switch the ICD off in a heart failure patient?\",\"authors\":\"L. Cheung\",\"doi\":\"10.1136/heartasia-2019-apahff.10\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"It is well documented that implantable cardioverter defibrillator (ICD) saves lives in populations at risk for sudden death. However, mortality in advanced heart failure remains high despite advances in therapy.1 Twenty per cent of ICD patients receiving shocks in the final weeks of their lives experience pain and decreased quality of life, causing distress to patients and their families.2 Ethically and legally, there are no differences between refusing ICD therapy and requesting withdrawal of ICD therapy. Carrying out a request to withdraw life-sustaining treatment is neither physician-assisted suicide nor euthanasia.3 Decisions about deactivation of ICD are complicated. Proactive communication by clinicians before implant and during device follow-up are important in order to minimise suffering as the end of life nears for patients with ICDs. Clear discussion about the benefits and burdens of the device should be made. Advance care planning addressing device deactivation should be encouraged for all patients with ICD.4 References Goldberger Z, Lampert R. Implantable Cardioverter-defibrillators: expanding indications and technologies. JAMA 2006;295;809–818 Goldstein NE, Lampert R, Bradley E, Lynn J, Krumholz HM. Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med2004;141:835–838. Lampert R, Hayes DL, Annas GJ, Farley MA, Goldstein NE, Hamilton RM, Kay GN, Kramer DB, Mueller PS, Padeletti L, Pozuelo L, Schoenfeld MH, Vardas PE, Wiegand DL, Zellner R; American College of Cardiology; American Geriatrics Society; American Academy of Hospice and Palliative Medicine; American Heart Association; European Heart Rhythm Association; Hospice and Palliative Nurses Association. HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm2010;7:1008–1026. BHF. ICD deactivation at the end of life: Principles and practice. 2013. https://www.bhf.org.uk/-/media/files/publications/hcps/icd-deactivation.pdf\",\"PeriodicalId\":12858,\"journal\":{\"name\":\"Heart Asia\",\"volume\":\"11 1\",\"pages\":\"A5 - A5\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1136/heartasia-2019-apahff.10\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Heart Asia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/heartasia-2019-apahff.10\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart Asia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/heartasia-2019-apahff.10","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

有充分的证据表明,植入式心律转复除颤器(ICD)可以挽救处于猝死风险人群的生命。然而,尽管治疗取得了进步,晚期心力衰竭的死亡率仍然很高20%的ICD患者在生命的最后几周受到电击,经历疼痛和生活质量下降,给患者及其家属造成痛苦在伦理和法律上,拒绝ICD治疗和要求退出ICD治疗没有区别。执行撤销维持生命治疗的请求既不是医生协助的自杀,也不是安乐死关于停用ICD的决定是复杂的。临床医生在植入前和设备随访期间的积极沟通对于减少icd患者生命末期的痛苦非常重要。应该明确讨论该设备的好处和负担。应鼓励所有icd患者提前制定护理计划,解决设备停用问题。参考文献Goldberger Z, Lampert R.植入式心律转复除颤器:扩大适应症和技术。张建军,张建军,张建军,等。中国医学杂志2006;29;809-818。临终关怀中植入式心律转复除颤器的管理。Ann Intern Med2004; 141:835-838。Lampert R, Hayes DL, Annas GJ, Farley MA, Goldstein NE, Hamilton RM, Kay GN, Kramer DB, Mueller PS, Padeletti L, Pozuelo L, Schoenfeld MH, Vardas PE, Wiegand DL, Zellner R;美国心脏病学会;美国老年医学会;美国临终关怀与缓和医学学会;美国心脏协会;欧洲心律协会;安宁疗护及缓和护理协会。HRS专家共识声明:心血管植入式电子设备(CIEDs)在接近生命末期或要求停止治疗的患者中的管理。心Rhythm2010; 7:1008 - 1026。BHF银行。ICD在生命末期停用:原则和实践。2013. https://www.bhf.org.uk/-/media/files/publications/hcps/icd-deactivation.pdf
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
10 When is it time to switch the ICD off in a heart failure patient?
It is well documented that implantable cardioverter defibrillator (ICD) saves lives in populations at risk for sudden death. However, mortality in advanced heart failure remains high despite advances in therapy.1 Twenty per cent of ICD patients receiving shocks in the final weeks of their lives experience pain and decreased quality of life, causing distress to patients and their families.2 Ethically and legally, there are no differences between refusing ICD therapy and requesting withdrawal of ICD therapy. Carrying out a request to withdraw life-sustaining treatment is neither physician-assisted suicide nor euthanasia.3 Decisions about deactivation of ICD are complicated. Proactive communication by clinicians before implant and during device follow-up are important in order to minimise suffering as the end of life nears for patients with ICDs. Clear discussion about the benefits and burdens of the device should be made. Advance care planning addressing device deactivation should be encouraged for all patients with ICD.4 References Goldberger Z, Lampert R. Implantable Cardioverter-defibrillators: expanding indications and technologies. JAMA 2006;295;809–818 Goldstein NE, Lampert R, Bradley E, Lynn J, Krumholz HM. Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med2004;141:835–838. Lampert R, Hayes DL, Annas GJ, Farley MA, Goldstein NE, Hamilton RM, Kay GN, Kramer DB, Mueller PS, Padeletti L, Pozuelo L, Schoenfeld MH, Vardas PE, Wiegand DL, Zellner R; American College of Cardiology; American Geriatrics Society; American Academy of Hospice and Palliative Medicine; American Heart Association; European Heart Rhythm Association; Hospice and Palliative Nurses Association. HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm2010;7:1008–1026. BHF. ICD deactivation at the end of life: Principles and practice. 2013. https://www.bhf.org.uk/-/media/files/publications/hcps/icd-deactivation.pdf
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Heart Asia
Heart Asia Medicine-Cardiology and Cardiovascular Medicine
CiteScore
2.90
自引率
0.00%
发文量
0
期刊最新文献
Antiplatelet agents for preventing pre-eclampsia and its complications. Statin adherence and persistence on secondary prevention of cardiovascular disease in Taiwan. Anaesthesia use in catheter ablation for atrial fibrillation: a systematic review and meta-analysis of observational studies Association of school hours with outcomes of out-of-hospital cardiac arrest in schoolchildren Clinical consequences of poor adherence to lipid-lowering therapy in patients with cardiovascular disease: can we do better?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1